These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [The role of polyol pathways in formation of diabetic cataracts]. SabasiĆski K; Andrzejewska-Buczko J Klin Oczna; 1997; 99(6):401-4. PubMed ID: 9685789 [TBL] [Abstract][Full Text] [Related]
12. Aldose reductase expression as a risk factor for cataract. Snow A; Shieh B; Chang KC; Pal A; Lenhart P; Ammar D; Ruzycki P; Palla S; Reddy GB; Petrash JM Chem Biol Interact; 2015 Jun; 234():247-53. PubMed ID: 25541468 [TBL] [Abstract][Full Text] [Related]
13. Aldose reductase, NADPH and NADP+ in normal, galactose-fed and diabetic rat lens. Lee SM; Schade SZ; Doughty CC Biochim Biophys Acta; 1985 Sep; 841(3):247-53. PubMed ID: 3927985 [TBL] [Abstract][Full Text] [Related]
14. Control of sorbitol metabolism in renal inner medulla of diabetic rats: regulation by substrate, cosubstrate and products of the aldose reductase reaction. Grunewald RW; Weber II; Kinne-Saffran E; Kinne RK Biochim Biophys Acta; 1993 Nov; 1225(1):39-47. PubMed ID: 8241288 [TBL] [Abstract][Full Text] [Related]
15. Aldose reductase inhibitors and the complications of diabetes mellitus. Tomlinson DR Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953 [No Abstract] [Full Text] [Related]
16. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats. Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425 [TBL] [Abstract][Full Text] [Related]